Dr. Reddy’s Announces the Launch of Zenataneâ„¢ (Isotretinoin Capsules USP)

[Business Wire] – HYDERABAD, India–(BUSINESSWIRE)– Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Zenataneâ„¢ (Isotretinoin Capsules USP) in 20 mg and 40 mg, a therapeutically equivalent generic … more

View todays social media effects on RDY

View the latest stocks trending across Twitter. Click to view dashboard

See who Dr. is hiring next, click here to view